Evidence map›Paper›PMID 41563438›Full record

ArticleEuropean archives of psychiatry and clinical neuroscience2026

Episodic memory deficits and processes in post-COVID condition.

Silvia Oliver-Mas, Jordi A Matias-Guiu, Cristina Delgado-Alonso, María Valles-Salgado, María José Gil-Moreno, Juan I López-Carbonero, Lucía Fernández-Romero, Constanza Cuevas, Alfonso Delgado-Álvarez, Jorge Matias-Guiu and 1 more

Abstract read
In one paragraph

Article in European archives of psychiatry and clinical neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Silvia Oliver-MasDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Jordi A Matias-GuiuDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Cristina Delgado-AlonsoDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
María Valles-SalgadoDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
María José Gil-MorenoDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Juan I López-CarboneroDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Lucía Fernández-RomeroDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Constanza CuevasDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Alfonso Delgado-ÁlvarezDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Jorge Matias-GuiuDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain.
Maria Diez-CirardaDepartment of Neurology. Hospital Clínico San Carlos. San Carlos Health Research Institute (IdISCC), Universidad Complutense de Madrid, C/Profesor Martín Lagos, 28040, Madrid, Spain. mdcirarda@salud.madrid.org.ORCID http://orcid.org/0000-0001-6768-189X

Funding

Fundación para el Conocimiento madri+d G63-HEALTHSTARPLUS-HSP4Instituto de Salud Carlos III CD22/00043Instituto de Salud Carlos III CM23/00094Instituto de Salud Carlos III FI20/000145Instituto de Salud Carlos III INT20/00079
6 · The paper itself

Abstract

Cognitive dysfunction is one of the most prevalent symptoms in patients with post-COVID condition (PCC) and episodic memory has been highlighted as one of the most impaired cognitive domains in these patients. However, few studies have specifically assessed episodic memory processes in these patients. This study aims to comprehensively investigate the memory function in patients with PCC. We conducted a cross-sectional study involving 157 patients with PCC and 74 healthy controls. Participants underwent a comprehensive neuropsychological assessment and memory assessment, including the Loewenstein-Acevedo Scale for Semantic Interference and Learning (LASSI-L), the Free and Cued Selective Reminding test (FCSRT), the Open-Trial Selective Reminding Test (OT-SRT), and a Mental Ability Questionnaire (FLEI). We compared groups and evaluated the correlation between episodic memory and neuropsychological and clinical assessments. Patients with PCC showed reduced performance on the LASSI-L, the FCSRT and the OT-SRT compared to controls. The memory scores showed positive moderate correlations with attention tests and positive low correlations with language, visuospatial or executive functions. Subjective memory complaints were related to poorer memory performance. LASSI-L was the test most associated with subjective memory complaints, whereas OT-SRT was the test less influenced by attention tests. The study found multiple memory processes impaired in patients with PCC, specifically in initial encoding, learning information acquisition and storage, and in retrieval, with only partial improvement with cues and recognition, and with significant susceptibility to the effects of retroactive semantic interference. These findings are relevant for characterising the cognitive deficits of patients with PCC and for designing interventional strategies.

Indexed as

Cognitive DysfunctionCOVID-19Memory DisordersMemory, EpisodicAdultAgedCross-Sectional StudiesFemaleHumansMaleMiddle AgedNeuropsychological TestsPost-Acute COVID-19 SyndromeCognitionCOVID-19Long COVIDMemoryNeuropsychology

Identifiers

PMID41563438
PMCPMC13233641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.